HomeCancer

Cancer

Prostate

Dr. Stratton on noteworthy side of trial of relugolix and enzalutamide in high-risk prostate most cancers

Editor -
On this video, Kelly L. Stratton, MD, FACS, discusses a noteworthy side of a section 1B trial evaluating relugolix (Orgovyx) and enzalutamide (Xtandi)...
Cancer

Native firm builds dream playset for younger most cancers affected person

Editor -
Spencerport, N.Y. — Surprise Home windows, Showers and Baths teamed up with Roc Strong Basis on Saturday to construct a dream playset for...
Brain

Ga. Sheriff’s Workplace Throws Get together for 4-Yr-Outdated with Terminal Mind Most cancers

Editor -
Research

Lemonade stand helps most cancers analysis – CTV Information Kitchener

Editor -
Lemonade stand helps most cancers analysis  CTV Information Kitchener
Breast

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast most cancers

Editor -
Information descriptionGenomic sequencing knowledge for this venture was taken primarily from 94 TNBC samples included within the MyBrCa cohort tumour sequencing venture. Briefly,...
1...190191192...832Page 191 of 832

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.